• Reference Citation Analysis
  • v
  • v
  • Find an Article
Find an Article PDF (5081207)   Today's Articles (1159)
For: Kim TE, Shin MK. De novo case of lichenoid eruption following dupilumab treatment. JAAD Case Rep 2021;13:71-2. [PMID: 34189218 DOI: 10.1016/j.jdcr.2021.04.035] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]  Open
Number Cited by Other Article(s)
1
Bhanja DB, Sil A, Maiti A, Biswas SK. Clinical Profile of Patients with Lichenoid Drug Eruption: A Observational Study. Indian J Dermatol 2024;69:137-144. [PMID: 38841229 PMCID: PMC11149809 DOI: 10.4103/ijd.ijd_878_23] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/07/2024]  Open
2
Gustafson D, Wolf JE, Lester L, Sander H. Perforating lichen nitidus in the setting of atopic dermatitis. J Cutan Pathol 2024;51:108-113. [PMID: 37828706 DOI: 10.1111/cup.14545] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/29/2023] [Revised: 09/10/2023] [Accepted: 09/27/2023] [Indexed: 10/14/2023]
3
Tsai JH, Tsai TF. A Review of Dupilumab-Induced Adverse Events to Dermatologists and the Potential Pathogenesis in the Treatment of Atopic Dermatitis. Dermatitis 2024;35:24-42. [PMID: 37205852 DOI: 10.1089/derm.2022.0096] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/21/2023]
4
Derbyshire M, Beatty C, Marks K, Kazlouskaya V. Lichenoid eruption during treatment of atopic dermatitis with dupilumab. Int J Dermatol 2023;62:1202-1203. [PMID: 36250258 DOI: 10.1111/ijd.16465] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/25/2022] [Revised: 09/06/2022] [Accepted: 10/07/2022] [Indexed: 12/01/2022]
5
Zemlok SK, Buuh S, Brown R, Murphy M, Hegde UP, Mallett JR. Nivolumab-induced lichen planus responsive to dupilumab treatment in a patient with stage III C melanoma. JAAD Case Rep 2023;38:23-26. [PMID: 37600740 PMCID: PMC10433324 DOI: 10.1016/j.jdcr.2023.05.036] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 08/22/2023]  Open
6
Gajraj FA, Zahir J, Adereti C, Gajraj MH. A Case Report and Literature Review of the Role of Dupilumab in the Management of Lichen Planus: Cause or Treatment? Cureus 2023;15:e41274. [PMID: 37533618 PMCID: PMC10392291 DOI: 10.7759/cureus.41274] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 07/01/2023] [Indexed: 08/04/2023]  Open
7
Rehan Z, Pratt MD, Teo I, Petkiewicz S, Ayroud Y, Evans J, Pratt ME. Lichenoid-granulomatous drug reactions to dupilumab: A report of 2 cases. JAAD Case Rep 2023;33:13-16. [PMID: 36798857 PMCID: PMC9925838 DOI: 10.1016/j.jdcr.2022.12.013] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/05/2023]  Open
8
Kern L, Kleinheinrich L, Feldmann R, Sator P, Stella A, Breier F. Dupilumab-Induced Lichen Planus: A Case with Oral and Cutaneous Eruptions. Case Rep Dermatol 2022;14:356-361. [PMID: 36655064 PMCID: PMC9841792 DOI: 10.1159/000527918] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/04/2022] [Accepted: 10/23/2022] [Indexed: 12/02/2022]  Open
9
Markovitz NH, Pedersen E, Sachs DL, Bresler SC. Annular lichenoid eruption following treatment with casirivimab/imdevimab for COVID-19. JAAD Case Rep 2022;27:156-158. [PMID: 35845347 PMCID: PMC9273519 DOI: 10.1016/j.jdcr.2022.07.007] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]  Open
10
Okune M, Okiyama N, Fukuzono M, Sasaki K, Nomura T. Development of systemic lupus erythematosus after dupilumab treatment in a case of atopic dermatitis. J Dermatol 2022;49:556-559. [PMID: 35224748 DOI: 10.1111/1346-8138.16322] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/04/2021] [Accepted: 01/12/2022] [Indexed: 11/30/2022]
11
Kim YJ, Lee MY, Won CH. Acral erythema arising in patients with atopic dermatitis after dupilumab therapy: A case report of 3 patients. Asia Pac Allergy 2022;12:e1. [PMID: 35174052 PMCID: PMC8819416 DOI: 10.5415/apallergy.2022.12.e1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/12/2021] [Accepted: 01/08/2022] [Indexed: 11/04/2022]  Open
PrevPage 1 of 1 1Next
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA